[2] 赵振江，赵瑞斌，姚泽忠. 建立幼龄SD 大鼠肺炎克雷伯杆菌肺炎 模型的一种新方法[J]. 中国现代医生，2 009，1 9(5): 64-67.
[2] Salvatore CM，Techasaensiri C，Tagliabue C，et al. Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia [J]. Antimicrob Agents Chemother, 2009, 53(4): 1546-1551.
[3] 苗明三. 实验动物和动物实验技术[M]. 北京: 中国中医药出 版社，2 003: 143.
[4] Chung Dr，Huang SG，Wang H, et al. High prevalence of multidrugresistant nonfermenters in hospital-acquired pneumonia in asia[J]. Am J respir Crit Care Med，2011，1 84(8): 1409-1417.
[5] 单绍臣. 金黄色葡萄球菌L 型致间质性肺炎动物模型的建立 [J]. 中国微生态杂志，2 002，1 4(1): 23-24.
[6] Goodyear A，Jones A，Troyer r，et al. Critical protective role for MCP-1 in pneumonic Burkholderia mallei infection [J]. J Immunol, 2010，1 84(3): 1445-1454.
[7] Yost CS，Daud A，Gropper MA. Implementation of a high-dose interleukin-2 immunostimulation biotherapy program[J]. ICU Director，2010，1: 77-81.
[8] Haddad EA，Senger LK，Takei F. An accessory role for B cells in the IL-12-induced activation of resting mouse NK cells[J]. J Immunol, 2009，1 83(9): 3608-3615.